IMPROVEMENT OF SIMVASTATIN SOLUBILITY USING NATURAL POLYMERS BY SOLID DISPERSION TECHNIQUE
Keywords:
Chitosan, Oats powder, Solid dispersion, Simvastatin, Oral bioavailability, Karaya GumAbstract
The solubility of the poorly soluble drugs can be improved by various techniques such as micronization[1], solubilization[2], salt formation[1], complexation[1] with polymers, change in physical form, use of prodrugs[1] and drug derivatization[1], pH alteration, addition of surfactants[3,4] , and others. Serajuadin [5] used the solid-dispersion technique for dissolution enhancement of poorly water-soluble drugs. A solid dispersion can be defined as “the dispersion of one or more active ingredients in an inert carrier matrix in solid-state prepared by a physical mixture, melting (fusion), solvent, or melting–solvent method,” while Corrigan[6] suggested it is “a product formed by converting a fluid drug–carrier combination to the solid state.” Among the various approaches, the solid-dispersion technique has often proved to be the most successful in improving the dissolution and bioavailability of poorly soluble, active pharmaceutical ingredients because it is simple, economical, and advantageous. Simvastatin (SIM), a crystalline compound, is practically insoluble in water and hence poorly absorbed from the GI tract [7,8] . It is a potent and specific inhibitor of 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG CoA) reductase [9, 10], which catalyzes the reduction of HMG CoA to mevalonate. Thus, simvastatin arrests a key step for cholesterol biosynthesis in the liver and is widely used in the treatment of hypercholesterolemia and dyslipidemia as an adjunct to diet. After oral administration, Simvastatin is metabolized to its β-dihydroxy acid form (simvastatin acid) by the cytochrome-3A system in the liver, where it inhibits the rate-limiting step in cholesterol biosynthesis. This leads to up-regulation of low-density lipoprotein (LDL) receptors and an increase in catabolism of LDL cholesterol. Being a BCS Class II drug, it often shows dissolution rate-limited oral absorption and high variability in pharmacological effects. Therefore, improvement in its solubility and dissolution rate may lead to enhancement in bioavailability [11]. In the present study, of solid dispersion physical mixture technique was used and solubility of drug was improved by using some natural polymers like Xanthum gum, Guar gum, Karaya gum, Chitosan and Oats powder.
References
[1] Pinnamaneni, N. G.; Das, N. G.; Das, S. K. Formulation approaches for orally administered poorly soluble drugs. Pharmazie, 2002, 57 (5), 291–300. [2] Carlota, O.; Rangel, Y.; Adalberto, P.; Leoberto, C. T. Micellar solubilization of drugs. J. Pharm. Pharm. Sci, 2005, 8 (2), 147–163.
[3] Nokhodchi, A.; Javadzadeh, Y.; Reza, M.; Barzega, J. M. The effect of type and concentration of vehicles on the dissolution rates of a poorly water soluble drug indomethacin from liquisolid compacts. J. Pharm. Pharm. Sci, 2005, 8 (1), 18–25. [4] Leuner, C.; Dressman, J. Improving drug solubility for oral delivery using solid dispersions. Eur. J. Pharm. Biopharm, 2000, 50 (1), 47–60. [5] Serajuddin, A. Solid Dispersion of Poorly Water-Soluble Drugs: Early Promises, Subsequent Problems, and Recent Breakthroughs. J. Pharm. Sci, 1999, 88 (10), 1058–1066. [6] Craig, D. Q. M. The mechanisms of drug release from solid dispersions in water-soluble polymers. Int. J. Pharm, 2002, 231 (2), 131–144. [7] Kang, B. K.; Lee, J. S.; Chon, S. K.; Jeong, S. Y.; Yuk, S. H.; Khang, G.; Lee, B. H.; Cho, S. H, Development of self micro emulsifying drug delivery systems (SMEDDS) for oral bioavailability enhancement of simvastatin in beagle dogs. Int. J. Pharm, 2004, 274 (1–2), 65–73. [8] Ambike, A. A.; Mahadik, K. R.; Paradkar, A. Spray-Dried Amorphous Solid Dispersions of Simvastatin, a Low Tg Drug; In Vitro and In Vivo Evaluations. Pharm. Res. 2005, 22 (6), 990–998.
[9] Cheng, H.; Sutton, S. C.; Pipikin, J. D.; Zentner, G. M.; Rogers, J. D.; Schwartz, J. I.; Mitchel, Y. B.; Grasing, K.; Schwartz, M. S.; Amin, R. D.; Liu, L.; Ebel, D. L.; Coulter, A.; Engle, K.; McClelland, G. A.; Lui, C. Y.; Rork, G. S. Evaluation of sustained/controlled-release dosage forms of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor in dogs and humans. Pharm. Res, 1993, 10 (11), 683–1687.
[10] McClelland, C. A.; Stubbs, R. J.; Fix, J. A.; Pogany, S. A.; Zentner, G.M. Enhancement of 3-hydroxy-3- methyl glutaryl-coenzyme A (HMG CoA) reductase Inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form. Pharm. Res, 1991, 8 (7), 873–876.
[11] Dixit, R. P.; Nagarsenker, M. S. In vitro and in vivo advantage of celecoxib surface solid dispersion and dosage form development. Ind. J. Pharm. Sci. 2007,69 (3), 370–377.
[12] Punitha.S and Senthil Kumar. K.L, Evaluation of solubility of simvastatin using β cyclodextrin by solid dispersion technique, IJBR 1 [2] 2010.
[13] Srinivas, M.; Parambil, A.; Krishnan, M.; Achuta, N. U. Enhancement of dissolution rate and bioavailability of aceclofenac: A chitosan-based solvent change approach. Int. J. Pharm. 2008, 350 (1–2), 279–290.
Downloads
Published
License
Copyright (c) 2013 INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH AND BIOMEDICAL ANALYSIS

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at www.ijprba.com
"The content of IJPRBA journal and the published Manuscripts are copy right protected. Commercial usage of the same is prohibited.
Click here for obtaining Permission for commercial use"